FibroBiologics, Inc. Common Stock (FBLG) — Defensive Interval Ratio

Latest as of December 2022: 15 days

FibroBiologics, Inc. Common Stock (FBLG) has a Defensive Interval Ratio of 15 days as of December 2022. Defensive assets of $300.00K (cash $-, short-term investments $-, receivables $300.00K) cover 15 days of daily cash needs of $19.38K/day. Check FBLG goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

15 days
Days of operational coverage

Defensive Assets

$300.00K
Cash + ST Investments + Receivables

Daily Cash Need

$19.38K
Current Liabilities ÷ 365

Current Liabilities

$7.07 Million
USD

FibroBiologics, Inc. Common Stock Defensive Interval Ratio (2023–2023)

This chart shows how FibroBiologics, Inc. Common Stock's Defensive Interval Ratio has evolved across 1 annual periods from 2023 to 2023. As of December 2022, the ratio stands at 15 days, meaning defensive assets of $300.00K can fund 15 days of operations without new revenue. Also explore FibroBiologics, Inc. Common Stock annual equity growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for FibroBiologics, Inc. Common Stock (2023–2023)

The table below presents the year-by-year Defensive Interval Ratio for FibroBiologics, Inc. Common Stock from 2023 to 2023, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see FBLG market cap.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2023 15 days $300.00K $19.38K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)